Pharmaceuticals and healthcare


moves, lateral hires and exits

Norton Rose hit with mass defection as 15-strong team exit to Reed Smith

A team of 15 lawyers across four different Norton Rose Fulbright offices in the US have decamped to join Reed Smith. The team includes global head of life sciences and healthcare Rick Robinson, Washington partner Lesley Reynolds, Austin partners Jeff Layne and Ben Koplin and New York partner Cori Goldberg. Two Norton Rose associates, Washington […]

Daniel Brook, pharma litigation, Hogan Lovells

Brook, Daniel – Hogan Lovells

As a former chemistry student, Hogan Lovells IP partner Daniel Brook has honed his legal and science knowledge to become indispensable to several of the world’s largest pharmaceutical companies looking to safeguard their products. One of the most important judgments last year was Eli Lilly’s landmark patent trial against pharmaceutical rival Actavis. Brook took the […]



Pinsents acting as pressure mounts on Deloitte over Scottish role

As part of the ongoing dispute that sees Addleshaw Goddard caught up in the insolvency of a string of family-owned caravan parks, Pinsent Masons has been called on to defend big four accountancy firm Deloitte from a professional negligence claim for advice it gave during that same insolvency. In May, The Lawyer reported that City-based Pinsents partners […]

Redundancy fears at BT spread to in-house legal team

BT group general counsel Sabine Chalmers has written to lawyers at the telecomms business in a bid to curb fears over job losses which have now spread to its legal team. BT CEO Gavin Patterson has been the most high-profile casualty of the business’s recent struggles as he was asked to step down by shareholders […]

billable hours

The speed read: the legal world’s key stories of last week

There are three things that keep City managing partners awake at night. First, the US firms. Second, tech and New Law. And third, Brexit. This week saw all three issues in the spotlight. The extent of US firms’ growth in London was shown by the unveiled City 50, The Lawyer’s ranking of US and UK […]


White & Case advises as CVC buys UnitedLex in biggest-ever legal market deal

CVC Capital Partners has acquired a majority stake in alternative legal services provider UnitedLex in what is believed to be the largest investment in the legal market ever at $500m. UnitedLex CEO Dan Reed led negotiations in-house. The Lawyer can reveal that CVC was advised by a White & Case team led by New York-based partner […]

New York Stock Exchange

Orrick and Latham advise on FarFetch float

Orrick, Latham & Watkins and Fenwick & West have taken the lead advising on luxury online retailer FarFetch‘s IPO on the New York Stock Exchange. Latham & Watkins is advising FarFetch, with a capital markets team led by New York partners Marc Jaffe and Ian Schuman, and London partner Joshua Kiernan. Orrick is acting for a […]

Nicola Dagg

Revealed: A&O’s IP reshuffle in the wake of Dagg’s Kirkland move

Former Allen & Overy (A&O) head of intellectual property Nicola Dagg was leading on 75 per cent of the firm’s cases in the sector before the announcement of her high-profile move to US firm Kirkland & Ellis earlier this year, data from The Lawyer can reveal. Data gathered for The Lawyer Litigation Tracker Q2  shows that of the firm’s four […]

New York City

LOD targets US as future biggest market in growth strategy

Flexible lawyering service Lawyers On Demand (LOD) has laid out its plans for significant growth in the US with hopes that it will become the provider’s biggest market in the next “few years”. In a bid to further its ambitions in the US, LOD co-founder John Knox relocated to the North Eastern state of Connecticut […]

Featured Briefings

Higher Dutch VAT rate on several LS-products

By Luca van Silfhout, Patrick Vettenburg A number of goods and services, listed in an annex to the Dutch VAT Act, qualify for the reduced VAT rate (instead of the regular VAT rate of currently 21%). Among these goods and services are: qualifying medicines, first-aid type supplies such as bandages and qualifying medical aids such […]

Promotion of indigenous R&D in pharmaceutical industry by the Delhi High Court

By Ajay Bhargava, Arvind Kumar Ray, Karan Gupta In the recent case of Modi-Mundipharma Private Limited v Union of India & Ors., (Writ Petition (Civil) No. 11802 of 2016), the High Court of Delhi (Court) has clarified that incremental innovation or novel drug delivery systems like lipid / liposomal formulations, sustained release, controlled release, etc. should […]

CSP Regulations- An Overview

By Alexander Camenzind On September 21, 2017, the Certificate of Supplementary Protection Regulations (“CSP Regulations”) came into force, providing for the first time the ability to obtain an extended period of patent protection for human and veterinary drugs in Canada. With the first anniversary of the program quickly approaching, an overview of its implementation may prove […]

Opportunity for employees and residents to become co-owners of Brabant hospital

By Martin Schoonewille, Frank Leijdesdorff, Leon Engelen The hospital Bernhoven in Uden and Oss gives employees the opportunity to buy bonds and thereby indirectly become ‘co-owners’ of the hospital. From 2019 local residents can also obtain bonds. The hospital hopes to increase the involvement of staff and patients, according to the press release. The hospital has a bank loan […]

Pricing and reimbursement insight- Mozambique

By Paulo Pinheiro, Francisca Paulouro, Pedro Fontes VdA contributes to the 1st edition of “Global Legal Insights: Pricing & Reimbursement” published by Global Legal Group. Some of the firm’s members have written the chapters for Portugal, Angola and Mozambique, which focus on, amongst others, the legislation regarding pricing and reimbursement of medicinal products in those countries.

Pricing and reimbursement insight- Angola

By Paulo Pinheiro, Francisca Paulouro, Pedro Fontes VdA contributes to the 1st edition of “Global Legal Insights: Pricing & Reimbursement” published by Global Legal Group. Some of the firm’s members have written the chapters for Portugal, Angola and Mozambique, which focus on, amongst others, the legislation regarding pricing and reimbursement of medicinal products in those countries.

Austria-Let them eat space cake

By: Andreas Natterer, Michaela Pohl, Thomas Kulnigg  The traditional Austrian bakery Aida, which is known for its staff dressed in baby pink, will sell brownies containing CBD. The price will be EUR 4.20 – an inside joke, since “four-twenty” is code for the consumption of cannabis. The fact that an old-school, stuffy bakery like Aida is […]

Ministry of Health, Welfare and Sport condemns price increase of CDCA drug

By Dieuwertje van Dijk Minister Bruins (Medical Care and Sport) of the Ministry of Health, Welfare and Sport ( VWS ) condemns the behavior of pharmaceutical Leadiant to the strong price increase of the drug CDCA. He wrote this in a letter to the House of Representatives last Monday . CDCA (chenodeoxycholic acid) is used as a medicine in the treatment […]

Support needed for growing mental health issues at work

Mental health is an issue that is becoming increasingly prevalent in both our home and working lives. According to statistics published by the Mental Health Foundation, nearly half (43.4%) of UK adults believe they have had a diagnosable mental health condition at some point in their life. According to a CIPD/Simplyhealth Health and Well-being at […]

Netherlands: Pharmaceutical companies in spotlight of competition watchdog

Dutch Minister of Medical Care initiates dialogue with the ACM concerning potential abuse of dominance by pharmaceutical companies. In a letter of 16 November 2017, the Minister addresses the complexity of the development of medicines and the problem that expensive medicines pose to the national health care budget. The Minister also announced that he will […]

Dutch Healthcare Authority issues fine for failure to notify a concentration

On 30 November 2017 the Dutch Healthcare Authority issued a fine of € 70.000 to a healthcare provider that failed to notify a concentration. The healthcare provider had acquired certain personnel from other healthcare providers and this transaction exceeded the 50 person threshold for notification to the Dutch Healthcare Authority. The Dutch Healthcare Authority qualified the […]

Luxembourg imposes Sunshine Act-like transparency obligations

Most people involved in the life sciences or healthcare sector are aware, or at least have heard of, the “Sunshine Act”. The “Sunshine Act”, now a familiar concept in the EU, is the abbreviated title of the 2010 US Physician Payments Sunshine Act, which was adopted as part of the Affordable Care Act (better known […]

Register now to The Lawyer to access our latest news stories, read selected briefings from key firms and gain essential careers insight to help you make the most of your current and future roles.

Contact Us: if you have any questions regarding your subscription, call us on +44 (0)20 7292 3716 or email us at

Register now

Having problems?

Contact us on +44 (0)20 7292 3716 | email:

If you are looking for our Jobs site, please click here